Vestal Point Capital »

Crescent Biopharma shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Crescent Biopharma (CBIO) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Crescent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Crescent Biopharma held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crescent Biopharma by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $18M 1.5M 11.86

More positions owned by Vestal Point Capital

Abivax SA Sponsored Ads (ABVX)
Invesco QQQ Trust Series 1 Unit Ser 1 Put Option (QQQ)
Arcellx Common Stock (ACLX)
Terns Pharmaceuticals (TERN)
BioMarin Pharmaceutical (BMRN)
Globus Medical Cl A (GMED)
Nurix Therapeutics (NRIX)
Alcon Ord Shs (ALC)
Dex (DXCM)
Merck & Co (MRK)
Taysha Gene Therapies Com Shs (TSHA)
Abbott Laboratories (ABT)
Immatics NV SHS (IMTX)
Tyra Biosciences (TYRA)
Bicara Therapeutics (BCAX)

View all positions for Vestal Point Capital

Top funds holding Crescent Biopharma

Fairmount Funds Management
VR Adviser
Fcpm Iii Services B.v.
Vestal Point Capital
FMR
BVF
Opaleye Management
Tang Capital Management
ADAR1 Capital Management
Logos Global Management
Vanguard Group
Perceptive Advisors
Deep Track Capital
Boxer Capital Management
Rtw Investments

View all funds holding Crescent Biopharma